Clinical Scorecard: ACP Suggests First-Line Obesity Drugs
At a Glance
| Category | Detail |
|---|---|
| Condition | Obesity and overweight with weight-related comorbidities |
| Key Mechanisms | Semaglutide and tirzepatide as first-line treatments; lifestyle modifications included. |
| Target Population | Nonpregnant adult patients with obesity (BMI ≥ 30 kg/m²) or overweight (BMI 27-<30 kg/m²) with comorbidities. |
| Care Setting | Outpatient management |
Key Highlights
- Semaglutide and tirzepatide recommended as first-line treatments based on moderate-certainty evidence.
- Phentermine-topiramate, liraglutide, and naltrexone-bupropion recommended as second to fourth-line treatments based on lower-certainty evidence.
- Both semaglutide and tirzepatide improved weight-loss outcomes and hemoglobin A1c.
- Phentermine-topiramate is suggested only for nonpregnant adults without established cardiovascular disease.
- All medications carry specific warnings and potential adverse effects.
Guideline-Based Recommendations
Diagnosis
- Obesity defined as BMI ≥ 30 kg/m².
- Overweight defined as BMI 27-<30 kg/m² with weight-related comorbidities.
Management
- First-line: Semaglutide and tirzepatide.
- Second-line: Phentermine-topiramate for obesity; liraglutide for overweight with comorbidities.
- Third-line: Liraglutide.
- Fourth-line: Naltrexone-bupropion.
Monitoring & Follow-up
- Monitor for weight loss, hemoglobin A1c, and adverse events.
Risks
- Potential thyroid C-cell tumor risk with semaglutide, tirzepatide, and liraglutide.
- Teratogenic risk with phentermine-topiramate.
Patient & Prescribing Data
Adults with obesity or overweight and weight-related comorbidities.
Discuss benefits, harms, costs, access, and contraindications before initiating treatment.
Clinical Best Practices
- Use lifestyle modifications alongside pharmacologic treatments.
- Consider patient-specific factors such as comorbidities and preferences.
Related Resources & Content
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
